found that the overexpression of CXCR4 (a GCSCs marker) was related to the poor prognosis of GC patients, while EPCAM and TFRC (two GCSCs marker) were positively associated with the prognosis of GC patients. This evidence concerns the gene EPCAM and gastric cancer.